N/A
Completed N=10
On-pump Intraoperative Echocardiography
Septal Myectomy
Source: ClinicalTrials.gov NCT03094325 ↗
Enrolled (actual)
10
Serious AEs
0.0%
Results posted
Mar 2020
Primary outcomePrimary: Septal Thickness Measured Before Cardiopulmonary Bypass — 22.9; 22.5 millimeters
Summary
This pilot study uses an ultrasound probe that is currently clinically used to assess pituitary anatomy, the Hitachi-Aloka high resolution pituitary transducer to measure left ventricular (LV) septal thickness during cardiopulmonary bypass in the performance of surgical septal myectomy. Septal thickness will be assessed and can be visualized during the procedure and if it is likely to improve the efficacy and safety of the procedure. The probe has FDA clearance for a variety of intra-operative surgical procedures but will be off-label for this cardiac surgical protocol.
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY Septal Thickness Measured Before Cardiopulmonary Bypass |
22.9; 22.5 | — |
Eligibility Criteria
Inclusion Criteria
- scheduled to receive a septal myectomy.
Exclusion Criteria
- Less than 18 years of age
Data sourced from ClinicalTrials.gov (NCT03094325). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication. Informational only — not medical advice.